Company page
Bridgebio Pharma, Inc.
Bridgebio Pharma, Inc. is a public company traded under the ticker BBIO in the American market. The company has a market capitalization of approximately $12.98 billion. Bridgebio focuses on developing innovative medicines for genetic diseases and cancers.
- Ticker
- BBIO:NASDAQ
- Asset type
- Stock
- Market cap
- $12.98B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD